Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancer.

[1]  J. Wesseling,et al.  Immunoscintigraphy of small-cell lung cancer xenografts with anti neural cell adhesion molecule monoclonal antibody, 123C3: improvement of tumour uptake by internalisation. , 1996, British Journal of Cancer.

[2]  H. Groen,et al.  Pharmacokinetics and scintigraphy of indium-111-DTPA-MOC-31 in small-cell lung carcinoma. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[3]  L. Hope-Stone,et al.  carcinoembryonic antigen: phase I/Il study with comparative biodistribution of intact and F(ab') antibodies , 2007 .

[4]  G. Riethmüller,et al.  Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma , 1994, The Lancet.

[5]  R. Pedley,et al.  Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy. , 1994, British Journal of Cancer.

[6]  R. Souhami,et al.  The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodies. , 1994, British Journal of Cancer.

[7]  G. Jaques,et al.  Evaluation of serum neural cell adhesion molecule as a new tumor marker in small cell lung cancer , 1993, Cancer.

[8]  R. Stahel,et al.  Monoclonal antibody SEN7 recognizes a new epitope on the neural cell adhesion molecule present on small cell lung cancer but not on lymphocytes. , 1993, Cancer research.

[9]  A. Perkins,et al.  Immunoscintigraphy of small-cell lung cancer: a study using technetium and indium labelled anti-carcinoembryonic antigen monoclonal antibody preparations. , 1993, British Journal of Cancer.

[10]  M. Spang‐Thomsen,et al.  Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts. , 1992, British Journal of Cancer.

[11]  J. Schlom,et al.  Therapeutic advantage of high-affinity anticarcinoma radioimmunoconjugates. , 1992, Cancer research.

[12]  R. Ueda,et al.  Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies. , 1991, The British journal of cancer. Supplement.

[13]  J. Broers,et al.  Biodistribution of a monoclonal antibody (RNL‐1) against the neural cell adhesion molecule (NCAM) in athymic mice bearing human small‐cell lung‐cancer xenografts , 1991, International journal of cancer.

[14]  R. Souhami,et al.  Antigens of lung cancer: results of the second international workshop on lung cancer antigens. , 1991, Journal of the National Cancer Institute.

[15]  H. Dvorak,et al.  Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. , 1991, Cancer cells.

[16]  W. Mooi,et al.  Effect of polarity and differentiation on antibody localization in multicellular tumour spheroid and xenograft models and its potential importance for in vivo IMMUNOTARGETING , 1989, International journal of cancer.

[17]  P. Keep,et al.  Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards and Control. , 1986, British Journal of Cancer.

[18]  P. Edwards.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies. , 1985, British Journal of Cancer.

[19]  G. Pelosi,et al.  Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small‐cell lung cancer (SCLC) with “limited” or “extensive” disease, and bone‐marrow infiltration , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[20]  J. Ledermann,et al.  Topography of ncam antigenic epitopes recognized by SCLC‐cluster‐1 antibodies. A consensus view , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[21]  N. van Zandwijk,et al.  NCAM and lung cancer , 1994, International journal of cancer. Supplement = Journal international du cancer. Supplement.

[22]  M. Mariani,et al.  A new enzymatic method to obtain high-yield F(ab)2 suitable for clinical use from mouse IgGl. , 1991, Molecular immunology.